UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 12, 2013
ARTHROCARE CORPORATION
(Exact name of registrant as specified in its charter)
Delaware |
|
0-027422 |
|
94-3180312 |
(State or other jurisdiction |
|
(Commission File Number) |
|
(I.R.S. Employer Identification |
of Incorporation) |
|
|
|
No.) |
7000 West William Cannon, Building One
Austin, TX 78735
(Address of principal executive offices, including zip code)
(512) 391-3900
(Registrants telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.07 Submission of Matters to a Vote of Security Holders
A special meeting of stockholders (the Special Meeting) of ArthroCare Corporation (the Company) was held on December 12, 2013. At the Special Meeting, the Companys stockholders voted on two proposals described in detail in the Companys Proxy Statement, dated October 23, 2013, and cast their votes as follows:
1. Proposal 1: To approve an amendment to the Companys Certificate of Incorporation amending the Certificate of Designations of the Series A 3.00% Convertible Preferred Stock to permit the size of the Board of Directors of the Company to be increased to a maximum of nine persons:
Votes For |
|
Votes |
|
Abstentions |
|
30,266,227 |
|
17,914 |
|
11,179 |
|
2. Proposal 2: For the election of Fabiana Lacerca-Allen as a member of the Board of Directors of the Company to serve until the Companys next annual meeting or until her successor is duly qualified and elected:
Votes For |
|
Votes |
|
Abstentions |
|
30,256,376 |
|
24,104 |
|
14,839 |
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
ARTHROCARE CORPORATION | |
|
| |
|
| |
Date: December 12, 2013 |
| |
|
|
|
|
By: |
/s/ David Fitzgerald |
|
David Fitzgerald | |
|
President and Chief Executive Officer |